# Does Erythropoietin Improve Outcome in Very Preterm Infants?

> **NCT00413946** · PHASE2 · COMPLETED · sponsor: **Swiss Neonatal Network** · enrollment: 420 (actual)

## Conditions studied

- Intracranial Hemorrhage
- Periventricular Leukomalacia
- Cerebral Palsy
- Developmental Psychomotor Disorders

## Interventions

- **DRUG:** Recombinant human Erythropoietin
- **DRUG:** saline

## Key facts

- **NCT ID:** NCT00413946
- **Lead sponsor:** Swiss Neonatal Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 420 (ACTUAL)
- **Last updated:** 2018-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00413946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00413946, "Does Erythropoietin Improve Outcome in Very Preterm Infants?". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00413946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*